
Dr. Sonja Wiedemann
CEO & CTO of lifespin
CEO & CTO of lifespin, Regensburg · Munich chapter
Sonja Wiedemann is CEO and CTO of lifespin, a Regensburg company that maps your metabolism from a single blood sample using NMR and AI. She gave the metabolomics talk at Longevity Germany's MetaboPRO event in Munich. Before lifespin, she ran Eurofins Genomics.
Highlights
- CEO & CTO of lifespin GmbH, a metabolomics diagnostics company in Regensburg (founded 2017).
- Former Managing Director at Eurofins Genomics, part of the Eurofins Scientific group.
- Leads lifespin's MetaboPRO test, which maps metabolism from hundreds of molecules in a single blood sample.
CEO & CTO of lifespin GmbH, a metabolomics diagnostics company in Regensburg (founded 2017).. Former Managing Director at Eurofins Genomics, part of the Eurofins Scientific group.. Leads lifespin's MetaboPRO test, which maps metabolism from hundreds of molecules in a single blood sample..
About Sonja Wiedemann
Topics & Expertise
- Metabolic Health
- Preventive Medicine
- Epigenetics & Biomarkers
- metabolomics
- nmr-based blood testing
- metabolic health biomarkers
- preventive diagnostics
- ai in diagnostics
- molecular biology
- precision medicine
Frequently Asked
Who is Sonja Wiedemann?
She is the CEO and CTO of lifespin, a Regensburg company that reads metabolism from a single blood sample using NMR and AI. Her background is in molecular biology and biochemistry, and she previously ran Eurofins Genomics.
What does Sonja Wiedemann speak about at Longevity Germany events?
Metabolomics: what a broad metabolic blood test can show about your health, and how it differs from a standard lab panel. In Munich she gave the talk and Q&A at the MetaboPRO testing event.
What is lifespin's MetaboPRO test?
MetaboPRO measures hundreds of molecules in your blood and maps your metabolism at a systems level, aiming to show where things are balanced and where early action could help.
What is Sonja Wiedemann's background?
She holds a doctorate and comes from molecular biology and biochemistry. Before lifespin she was a managing director at Eurofins Genomics, one of Europe's large genomics testing groups.
